Trust Company’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Trust Company's IONS Position: Q3 2026 in Review
Trust Company held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 250 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #431.
Trust Company first reported a position in IONS in Q2 2026 and has held it in 2 quarters since. The position peaked at $19.8K in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Trust Company held 250 shares of Ionis Pharmaceuticals worth $11.2K as of Q3 2026.
- Trust Company left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
- Ionis Pharmaceuticals made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #431 holding.
- Trust Company first reported a position in Ionis Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Trust Company's Ionis Pharmaceuticals position peaked at $19.8K in Q2 2026.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.